CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Economics

  • Events
  • Media Releases
  • Pacients
  • Economics
  • Investment
  • CTGCT
  • Rodrigo Ortiz
29 October 2025 Event Date: 23 October 2025 do: 23 October 2025 •

CTGCT Highlights Role of AI in Medicine at Austria-Slovenia Business Forum

On October 23, 2025, the "Austria – Slovenia: Connected for the Future" business forum happened in Vienna, uniting nearly 300 leaders from the economy, research, and diplomacy. The event, organized by SPIRIT Slovenia and ...

Vesna Austria Slovenia Business Forum
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Marketaccess
  • Regulation
  • CTGCT
  • Gregor Cuzak
10 October 2025

Academic developers for affordable medicines

CTGCT (Centre for the Technologies of Gene and Cell Therapy, at National institute of Chemistry, Ljubljana) has joined the statement to preserve the Hospital Exemption in the revised EU pharmaceutical legislation. The Joint Statement, ...

  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • ATMPs
  • Business Model
  • Economics
  • CTGCT
  • UCL
  • Gregor Cuzak
12 February 2025

Introduction to IP and commercialisation – by UCL

The workshop took place on February 3d and was attended by the CTGCT advanced partners only. It provided an in-depth discussion on Intellectual Property (IP) and the process of commercializing research findings. The session ...

  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Economics
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
22 January 2025

Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration

CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA

Erdera
  • Events
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • CTGCT
  • NIC
  • Rodrigo Ortiz
23 October 2024 Event Date: 9 October 2024 • 09:00 do: 11 October 2024 • 16:00

3rd Teaming Club Conference – Novi Sad

The CTGCT presented the project in the 3rd Teaming Club Conference in Novi Sad, Serbia.

1728588285187 (1)
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Laboratory
  • Marketaccess
  • Pre Clinical
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
2 October 2024 Event Date: 18 October 2024 −

Program Announcement CTGCT Conference, 18th Oct 2024

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Investment
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Hta 20230511 Banner 0
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Business Model
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Logistics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • UCL
  • Gregor Cuzak
17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

Pipeline By Number Of Projects
  • Articles
  • Events
  • Researchers
  • Economics
  • Investment
  • CTGCT
  • Gregor Cuzak
9 September 2023

TV Slovenija: Scientific development of advanced treatments

Science and Technology is RTV's news programme, offering viewers a weekly round-up of the most interesting events and news in the field of science and technology every Thursday, with in-depth features and analysis, guest ...

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna